![Horn Pharmaceutical Consulting - regulatory requirements, marketing authorisation, regulatory strategies, regulatory Authorities EMA, FDA, CTD , IMPD/IND, Variations and changes, orphan drug applications, SMEs ,Small and Medium-sized Enterprises Horn Pharmaceutical Consulting - regulatory requirements, marketing authorisation, regulatory strategies, regulatory Authorities EMA, FDA, CTD , IMPD/IND, Variations and changes, orphan drug applications, SMEs ,Small and Medium-sized Enterprises](https://www.horn-pharma.de/uploads/regulatory_affairs_training.jpg)
Horn Pharmaceutical Consulting - regulatory requirements, marketing authorisation, regulatory strategies, regulatory Authorities EMA, FDA, CTD , IMPD/IND, Variations and changes, orphan drug applications, SMEs ,Small and Medium-sized Enterprises
eCTD - Neue Wege der elektronischen Einreichung - Vernetzung elektronischer regulatorischer Prozesse -
![First steps towards ICH Q12: Leveraging process understanding & development data to define process Established Conditions - A3P - Industrie Pharmaceutique & Biotechnologie First steps towards ICH Q12: Leveraging process understanding & development data to define process Established Conditions - A3P - Industrie Pharmaceutique & Biotechnologie](https://www.a3p.org/wp-content/uploads/2020/01/ich-q12-first-steps-vague-64-a3P.jpg)